Great Lakes Advisors, LLC Bluebird Bio, Inc. Transaction History

Great Lakes Advisors, LLC

  • $10.8 Billion
  • Q3 2025

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 03, 2021
SELL
$16.59 - $33.89 $2.24 Million - $4.58 Million
-135,080 Closed
0 $0
Q4 2020

Feb 09, 2021
SELL
$27.5 - $37.92 $4.33 Million - $5.97 Million
-157,484 Reduced 53.83%
135,080 $5.85 Million
Q3 2020

Nov 04, 2020
BUY
$34.44 - $43.75 $7.57 Million - $9.62 Million
219,833 Added 302.25%
292,564 $15.8 Million
Q2 2020

Aug 07, 2020
BUY
$27.12 - $45.97 $1.97 Million - $3.34 Million
72,731 New
72,731 $4.44 Million

Others Institutions Holding BLUE

# of Institutions
14
Shares Held
20.2M
Call Options Held
0
Put Options Held
2K
View Full List

About bluebird bio, Inc.

BLUE Quotes by TradingView
  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $383M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Great Lakes Advisors, LLC Portfolio

Follow Great Lakes Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Lakes Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Lakes Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email